NO3174881T3 - - Google Patents

Info

Publication number
NO3174881T3
NO3174881T3 NO15744308A NO15744308A NO3174881T3 NO 3174881 T3 NO3174881 T3 NO 3174881T3 NO 15744308 A NO15744308 A NO 15744308A NO 15744308 A NO15744308 A NO 15744308A NO 3174881 T3 NO3174881 T3 NO 3174881T3
Authority
NO
Norway
Application number
NO15744308A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO3174881T3 publication Critical patent/NO3174881T3/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • A61K31/5025Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/01Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
    • C07C65/105Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups polycyclic
    • C07C65/11Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups polycyclic with carboxyl groups on a condensed ring system containing two rings
    • EFIXED CONSTRUCTIONS
    • E21EARTH OR ROCK DRILLING; MINING
    • E21BEARTH OR ROCK DRILLING; OBTAINING OIL, GAS, WATER, SOLUBLE OR MELTABLE MATERIALS OR A SLURRY OF MINERALS FROM WELLS
    • E21B7/00Special methods or apparatus for drilling
    • E21B7/04Directional drilling
    • E21B7/06Deflecting the direction of boreholes
    • EFIXED CONSTRUCTIONS
    • E21EARTH OR ROCK DRILLING; MINING
    • E21BEARTH OR ROCK DRILLING; OBTAINING OIL, GAS, WATER, SOLUBLE OR MELTABLE MATERIALS OR A SLURRY OF MINERALS FROM WELLS
    • E21B7/00Special methods or apparatus for drilling
    • E21B7/04Directional drilling
    • E21B7/06Deflecting the direction of boreholes
    • E21B7/062Deflecting the direction of boreholes the tool shaft rotating inside a non-rotating guide travelling with the shaft
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mining & Mineral Resources (AREA)
  • Geology (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Geochemistry & Mineralogy (AREA)
  • Environmental & Geological Engineering (AREA)
  • General Life Sciences & Earth Sciences (AREA)
  • Fluid Mechanics (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO15744308A 2014-07-28 2015-07-24 NO3174881T3 (https=)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462029676P 2014-07-28 2014-07-28

Publications (1)

Publication Number Publication Date
NO3174881T3 true NO3174881T3 (https=) 2018-08-25

Family

ID=53761420

Family Applications (2)

Application Number Title Priority Date Filing Date
NO12797323A NO2719005T3 (https=) 2014-07-28 2012-05-17
NO15744308A NO3174881T3 (https=) 2014-07-28 2015-07-24

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO12797323A NO2719005T3 (https=) 2014-07-28 2012-05-17

Country Status (37)

Country Link
US (5) US9944650B2 (https=)
EP (1) EP3174881B1 (https=)
JP (1) JP6592503B2 (https=)
KR (1) KR20170033427A (https=)
CN (1) CN106536524B (https=)
AP (1) AP2017009700A0 (https=)
AU (1) AU2015295120B2 (https=)
BR (1) BR112017001160A2 (https=)
CA (2) CA2956421C (https=)
CL (1) CL2017000223A1 (https=)
CO (1) CO2017001918A2 (https=)
CY (1) CY1120602T1 (https=)
DK (1) DK3174881T3 (https=)
DO (1) DOP2017000018A (https=)
EA (1) EA032654B9 (https=)
ES (1) ES2670444T3 (https=)
GT (1) GT201700016A (https=)
HR (1) HRP20180788T1 (https=)
HU (1) HUE037571T2 (https=)
IL (1) IL250104B (https=)
LT (1) LT3174881T (https=)
MX (1) MX374539B (https=)
MY (1) MY187251A (https=)
NI (1) NI201700006A (https=)
NO (2) NO2719005T3 (https=)
PE (1) PE20170527A1 (https=)
PH (1) PH12017500159B1 (https=)
PL (1) PL3174881T3 (https=)
PT (1) PT3174881T (https=)
RS (1) RS57242B1 (https=)
SG (1) SG11201700419SA (https=)
SI (1) SI3174881T1 (https=)
SM (1) SMT201800260T1 (https=)
SV (1) SV2017005368A (https=)
TN (1) TN2017000018A1 (https=)
WO (1) WO2016016618A1 (https=)
ZA (1) ZA201701207B (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO2719005T3 (https=) * 2014-07-28 2018-01-20
CN110317216A (zh) * 2018-03-28 2019-10-11 首都医科大学 一种三唑并哒嗪类衍生物在医药领域的应用
TWI816880B (zh) * 2018-09-13 2023-10-01 大陸商恒翼生物醫藥(上海)股份有限公司 治療前列腺癌之組合療法
EP4045049A1 (en) 2019-10-14 2022-08-24 Astrazeneca AB Combination therapy for treating a hematological malignancy
CA3166741A1 (en) 2020-01-09 2021-07-15 Astrazeneca Ab Combination therapy for treating cancer
CN113143930B (zh) * 2021-04-08 2023-05-30 深圳湾实验室 化合物在制备SARS-Cov-2 E蛋白抑制剂中的用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0525065D0 (en) * 2005-12-08 2006-01-18 Novartis Ag Organic compounds
AU2006322187A1 (en) 2005-12-08 2007-06-14 Novartis Ag Pyrazolo[1,5-a]pyridine-3-carboxylic acids as EphB and VEGFR2 kinase inhibitors
BRPI0821676A2 (pt) * 2007-12-21 2015-06-16 Astrazeneca Ab Composto, composição farmacêutica, e, processo para a preparação dos compostos.
ES2427917T3 (es) * 2009-02-10 2013-11-04 Astrazeneca Ab Derivados de triazolo [4,3-b] piridazina y sus usos para el cáncer de próstata
PE20120473A1 (es) * 2009-05-11 2012-05-27 Astrazeneca Ab [1,2,4]triazolo[4,3-b]piridazinas como ligandos del receptor de androgenos
ES2563057T3 (es) 2009-11-05 2016-03-10 Glaxosmithkline Llc Inhibidor de bromodominio de benzodiazepina
EP2721031B1 (en) * 2011-06-17 2016-01-20 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
US9422290B2 (en) 2012-11-13 2016-08-23 Boehringer Ingelheim International Gmbh Triazolopyridazine
NO2719005T3 (https=) * 2014-07-28 2018-01-20

Also Published As

Publication number Publication date
HRP20180788T1 (hr) 2018-06-29
NO2719005T3 (https=) 2018-01-20
EA201790179A1 (ru) 2017-07-31
JP2017522338A (ja) 2017-08-10
RS57242B1 (sr) 2018-07-31
TN2017000018A1 (en) 2018-07-04
DK3174881T3 (en) 2018-06-06
CY1120602T1 (el) 2019-12-11
SMT201800260T1 (it) 2018-07-17
CL2017000223A1 (es) 2017-08-25
US20180230158A1 (en) 2018-08-16
IL250104A0 (en) 2017-03-30
PH12017500159B1 (en) 2020-12-09
CA3185741A1 (en) 2016-02-04
NI201700006A (es) 2017-08-25
BR112017001160A2 (pt) 2017-11-14
MX2017001218A (es) 2017-05-01
PE20170527A1 (es) 2017-05-24
US10407432B2 (en) 2019-09-10
EA032654B1 (ru) 2019-06-28
AP2017009700A0 (en) 2017-01-31
MX374539B (es) 2025-03-06
ZA201701207B (en) 2018-12-19
EP3174881A1 (en) 2017-06-07
CN106536524A (zh) 2017-03-22
PH12017500159A1 (en) 2017-07-10
MY187251A (en) 2021-09-15
AU2015295120B2 (en) 2018-02-01
EA032654B9 (ru) 2019-07-31
EP3174881B1 (en) 2018-03-28
US20200055861A1 (en) 2020-02-20
WO2016016618A1 (en) 2016-02-04
US20210107905A1 (en) 2021-04-15
ES2670444T3 (es) 2018-05-30
US20170210747A1 (en) 2017-07-27
HUE037571T2 (hu) 2018-09-28
CA2956421A1 (en) 2016-02-04
SI3174881T1 (en) 2018-06-29
LT3174881T (lt) 2018-06-11
KR20170033427A (ko) 2017-03-24
SV2017005368A (es) 2017-05-12
AU2015295120A8 (en) 2017-02-09
SG11201700419SA (en) 2017-02-27
US10766905B2 (en) 2020-09-08
DOP2017000018A (es) 2017-03-15
CO2017001918A2 (es) 2017-05-10
JP6592503B2 (ja) 2019-10-16
US11407755B2 (en) 2022-08-09
GT201700016A (es) 2018-12-19
US9944650B2 (en) 2018-04-17
IL250104B (en) 2018-10-31
CA2956421C (en) 2023-03-14
PT3174881T (pt) 2018-05-25
AU2015295120A1 (en) 2017-02-02
CN106536524B (zh) 2019-11-15
US20230035133A1 (en) 2023-02-02
PL3174881T3 (pl) 2018-08-31

Similar Documents

Publication Publication Date Title
BR112016003450A2 (https=)
BR112016017664A2 (https=)
BR112016016432A2 (https=)
BR112016017265A2 (https=)
BR112016016924A2 (https=)
BR112016012568A2 (https=)
BR112016016364A2 (https=)
BR112016016329A2 (https=)
BR112016012729A2 (https=)
BR112016017526A2 (https=)
BR112016015798A2 (https=)
BR112016017660A2 (https=)
BR112016015779A2 (https=)
BR112016014434A2 (https=)
BR112016015768A2 (https=)
BR112016027343A2 (https=)
BR112016017739A2 (https=)
BR112016017221A2 (https=)
BR112016030993A2 (https=)
BR112016017378A2 (https=)
BR112016016965A2 (https=)
NO3174881T3 (https=)
BR112016015625A2 (https=)
BR112016015668A2 (https=)
BR112016016282A2 (https=)